Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Recent selection on immune response genes was identified across seven ethnicities.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

A mouse gene mutation increases the risk of skin cancer.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

CD2 might be a new treatment target for patchy alopecia areata.

Disruptions in skin microbiome can lead to seborrheic dermatitis.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Activating TLR3 boosts autophagy gene expression in skin cells.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

The spiny mouse regenerates ear tissue asymmetrically, with gene expression differences possibly explaining its unique healing abilities.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.